Understanding why some baby boomers with Hepatitis C don't receive effective treatment
Official title: Disparities in the Diffusion of Direct-Acting Antiviral Therapy for Hepatitis C among Baby Boomers: A Mixed-Methods Study
Funded at Weill Medical Coll of Cornell Univ · NIH-10630248 · Data updated 2026-11-12
This study is looking into why baby boomers, especially those from different racial and ethnic backgrounds, have a hard time getting treatment for Hepatitis C, and it aims to find ways to make it easier for them to access the care they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 1, 2020 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $650,167 |
| NIH project number | 5R01DK123205-04 |
| Project ID | NIH-10630248 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are baby boomers born between 1945 and 1965, particularly those from racial and ethnic minority backgrounds who have been diagnosed with Hepatitis C.
✕Less likely to help
Patients who are not baby boomers or those who do not have Hepatitis C may not benefit from this research.
What this research studies
This research investigates the barriers that prevent baby boomers, particularly those from racial and ethnic minority groups, from accessing direct-acting antiviral therapy for Hepatitis C. It employs a mixed-methods approach, combining quantitative data on treatment patterns with qualitative interviews of patients and healthcare providers to identify factors contributing to disparities in care. By analyzing national and state-level data, the study aims to uncover the reasons behind the low treatment rates and propose solutions to improve access for those affected. Patients will be surveyed to gather insights on their experiences and challenges in receiving care.
Why it matters
Potential benefit: If successful, this research could lead to improved access to life-saving Hepatitis C treatments for underserved populations.
How similar studies have gone: Previous research has shown that addressing barriers to treatment access can significantly improve health outcomes for patients with chronic diseases, indicating that this approach has potential for success.
Where this research is happening
-
Weill Medical Coll of Cornell Univ
New York, United States Active
Researchers
- Principal investigator: Shapiro, Martin F. — Weill Medical Coll of Cornell Univ
- Study coordinator: Shapiro, Martin F.
Related research
Other NIH-funded projects on the same topics.
-
Rational hepatitis C vaccine design guided by natural clearance patterns
A Johns Hopkins team is studying how some people naturally clear hepatitis C to guide a vaccine that could prevent infection.
-
Real-world patient and clinician preferences to improve prenatal care for women with OUD and HCV
Researchers are exploring how pregnant women with opioid use disorder and hepatitis C, along with their clinicians, would like to receive care to improve outcomes for moms and babies.
-
Co-infection patterns of HIV, hepatitis C, and sexually transmitted infections among rural people who inject drugs during an HIV outbreak
A small, patient-focused study will look at how HIV, hepatitis C, and other sexually transmitted infections occur together in rural people who inject drugs during an HIV outbreak, and what factors relate to these co-infections.
-
Low-threshold hepatitis C treatment in jail to help people released back to the community
A patient-friendly plan to test a simple, quick hepatitis C treatment in jail for people who use drugs, with care that continues after release.
-
Precise, rapid HCV detection from blood at the point of care
Aiming to provide a fast, easy blood test to detect hepatitis C right where care is delivered.
-
Hepatitis C screening tool used in the Emergency Department
A new ED screening tool helps identify people at risk for hepatitis C so they can get diagnosed and treated sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.